Prognostic Factors and Outcome of Patients with Adult Acute Lymphoblastic Leukemia Treated with the Hyper-CVAD Regimen: A Retrospective Study

Table 1

Baseline characteristics of ALL patients treated with the Hyper-CVAD regimen.

Baseline characteristics (N = 70)
Age mean ± SD (years)	36.61 ± 13.88
Age median [min, max]	36.5 [16, 73]
Gender (%)
Female	30 (42.9)
Male	40 (57.1)
Cell lineage (%)
B-cell ALL	54 (77.1)
T-cell ALL	16 (22.9)
Primary CNS involvement (%)	4 (5.71)
Ph+ (%)	8 (18.6)
Myeloid marker (%)	6 (10)
Bone marrow transplantation	16 (22.8)